Affordable Access

Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan.

Authors
Type
Published Article
Journal
Alimentary pharmacology & therapeutics
Publication Date
Volume
25
Issue
9
Pages
1105–1113
Identifiers
PMID: 17439512
Source
Medline
License
Unknown

Abstract

Rabeprazole-based therapies achieved 50% eradication of clarithromycin-resistant H. pylori, and even achieved good rates in extensive metabolizers. Accordingly, rabeprazole can be recommended as part of a first-line proton pump inhibitor-based triple therapy for H. pylori.

Statistics

Seen <100 times